Sanofi: Availability of the Pre-quarterly Results Communication

Sanofi: Availability of the Pre-quarterly Results Communication

ID: 462744

(Thomson Reuters ONE) -


Availability of the Pre-quarterly Results Communication


Paris, France - April 8, 2016 - Sanofi announces today its Pre-quarterly Results
Communication document is available on the "Investors" page of the company's
corporate website: http://en.sanofi.com/investors/events/Results/2016-
04-29_Results_Q1_2016.aspx

As for each quarter, Sanofi has prepared this document for consideration to
assist in the financial modeling of the Group's quarterly results. Sanofi's
first quarter results will be published on April 29, 2016.


About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes
therapeutic solutions focused on patients' needs. Sanofi has core strengths in
diabetes solutions, human vaccines, innovative drugs, consumer healthcare,
emerging markets, animal health and Genzyme. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY).

--------------------------------------------------------------------------------

Contacts:

Media Relations Investor Relations
Laurence Bollack Sébastien Martel
Tel.: + (33) 1 53 77 46 46 Tel.: + (33) 1 53 77 45 45
mr(at)sanofi.com ir(at)sanofi.com



Press release (PDF):
http://hugin.info/152918/R/2001668/738549.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Sanofi via GlobeNewswire
[HUG#2001668]







Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Glassdoor to Host Roundtable on Pay Equality April 12 -- Equal Pay Day -- Featuring Hillary Clinton, U.S. Gold Medalist Megan Rapinoe and Other Leading Experts Sandoz receives EC approval for subcutaneous route of administration in biosimilar Binocrit's® nephrology indication
Bereitgestellt von Benutzer: hugin
Datum: 08.04.2016 - 07:01 Uhr
Sprache: Deutsch
News-ID 462744
Anzahl Zeichen: 2078

contact information:
Town:

PARIS



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 256 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Sanofi: Availability of the Pre-quarterly Results Communication"
steht unter der journalistisch-redaktionellen Verantwortung von

Sanofi (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Sanofi



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z